(Q35739660)

English

Relationship between vitreous and serum vascular endothelial growth factor levels, control of diabetes and microalbuminuria in proliferative diabetic retinopathy

scientific article published on 26 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Relationship between vitreous and serum vascular endothelial growth factor levels, control of diabetes and microalbuminuria in proliferative diabetic retinopathy (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

0 references

0 references

author name string

Nader Baharivand

1

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Nosratollah Zarghami

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Farid Panahi

3

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

M Yazdan Dokht Ghafari

4

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Ali Mahdavi Fard

5

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Abbas Mohajeri

6

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

language of work or name

0 references

publication date

26 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Clinical Ophthalmology

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

185-191

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Diabetic retinopathy: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273407

12 July 2018

Software for reading and grading diabetic retinopathy: Aravind Diabetic Retinopathy Screening 3.0.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273407

12 July 2018

Diabetic retinopathy: the latest in current management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273407

12 July 2018

Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273407

12 July 2018

Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273407

12 July 2018

Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273407

12 July 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273407

12 July 2018

Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273407

12 July 2018

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273407

12 July 2018

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273407

12 July 2018

Pathologic classification of diabetic nephropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273407

25 September 2018

Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273407

25 September 2018

Elevated vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273407

25 September 2018

Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273407

25 September 2018

American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination Survey.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273407

25 September 2018

Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3273407

25 September 2018

The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22331976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nitric oxide and vascular endothelial growth factor concentrations are increased but not related in vitreous fluid of patients with proliferative diabetic retinopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22331976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22331976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor levels in vitreous and serum of patients with either proliferative diabetic retinopathy or proliferative vitreoretinopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22331976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22331976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22331976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors influencing the development of visual loss in advanced diabetic retinopathy. Diabetic Retinopathy Study (DRS) Report No. 10

1 reference

https://pubmed.ncbi.nlm.nih.gov/22331976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: Diabetic Retinopathy Vitrectomy Study Report 5

1 reference

https://pubmed.ncbi.nlm.nih.gov/22331976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[A comparative study of vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy]

1 reference

https://pubmed.ncbi.nlm.nih.gov/22331976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22331976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22331976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22331976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subretinal fibrosis in diabetic macular edema. ETDRS report 23. Early Treatment Diabetic Retinopathy Study Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22331976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22331976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetic retinopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22331976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical factors related to the aqueous levels of vascular endothelial growth factor and hepatocyte growth factor in proliferative diabetic retinopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22331976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2147/OPTH.S27423

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35739660&oldid=1868310642"